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Abstract
Objective: Lipoblastoma is a rare neoplasm that occurs mostly in infants and children. Although benign, it has a
tendency for local recurrence.
Results: Clinical and pathological features of 23 cases of lipoblastoma described. Patients’ age ranged from 8 months
to 18 years with mean and median age 4.1 and 2.5 years, respectively. Male:female ratio was 2.8:1. Most common sites
were lower extremities (9 cases), followed by abdominal cavity and retroperitoneum (4 cases), and scrotum/groin (3
cases). Grossly, 22 tumors were well circumscribed and multi nodular. All cases showed lobules composed of adi‑
pocytes and lipoblasts with intervening fibrous septa and fine vascular network. Myxoid change, capsule formation
and septation were seen in all cases. Zonation was seen in 2 cases. Follow-up was available in 14 out of 23 patients.
Of these, 13 were alive and free of disease with no evidence of any recurrent lesion. One patient with a mediastinal
infiltrating lipoblastoma experienced 4 recurrences. Lipoblastoma is a benign adipocytic neoplasm of infants and
young children. Correlation of clinical and histological features helps in reaching a correct diagnosis. Owing to a high
recurrence rate following incomplete resection, a complete resection is essential. Prognosis is excellent after complete
resection.
Keywords: Lipoblastoma, Adipocyte, Benign, Recurrence
Introduction
Lipoblastomas are rare benign usually encapsulated neoplasms of infants and children, more common in males
with a tendency for local recurrence, first described as
lipoblastic tumors in infants and children under 3 years
composed of fetal adipose tissue [1–5].
Local recurrence is common, up to 80%, in incompletely
resected tumors [6–8]. Complete surgical excision is
essential to prevent recurrence. Grossly, pale yellow, myxoid cut surface with small cystic foci and microscopically,
lobules composed of immature adipose tissue separated
by fibrous septa and lipoblasts in different stages are seen
with no atypia or mitoses, plexiform capillary network

and mature adipose tissue are seen in the central part
of the lobules [9]. Lipoblastomas arise from embryonic
white fat as rapidly enlarging masses. Most common locations include extremities and trunk [10–15]. Lipoblastomas have been reported in head and neck [12, 13, 16–21],
mediastinum, axilla, labia, vulva, abdomen, retroperitoneum, groin, inguinoscrotal, and gluteal region [14–16,
22–27]. Lipoblastomatosis is reserved for lesions which
demonstrate infiltrative growth [2, 8, 11, 16, 20, 21].
We report 23 cases and this series is the largest from
the Indian sub-continent. Our aim was to describe the
clinicopathological features of lipoblastomas which are
important in their accurate diagnosis and differentiation from histologically similar neoplasms. The follow up
information will help us understand their behavior.
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Main text
Materials and methods

We searched the surgical pathology database of the two
collaborative tertiary care hospitals Aga Khan University
Hospital, Karachi, Pakistan and French Medical Institute for Mothers and Children, Kabul, Afghanistan. We
retrieved 23 cases diagnosed as “Lipoblastoma” between
2006 and 2016. Inclusion criteria were presence of admixture of adipocytes and lipoblasts, primitive mesenchymal
cells, plexiform vascular network and fibrous septations.
Cases in which expression of immunohistochemical
(IHC) markers (S100, CD34 and Desmin) was incompatible with histological features were excluded. Patients
above 20 years were not included. Existing co-morbidities such as congenital heart disease or diabetes mellitus
led to exclusion. Demographic data including patients’
age, gender, presenting complaints, tumor location,
size and gross appearance was available from pathology
reports. Hematoxylin and eosin and immunohistochemical slides were reviewed for microscopic features. We
looked for zonation, myxoid change, lobulation and IHC
expression. Slides were stained with CD34 (Ready To Use
[RTU] Monoclonal antibody, QBEnd 10 clone, Dako),
S100 (RTU Polyclonal antibody, Dako) and Desmin (RTU
Monoclonal antibody, D33 clone, Dako). Follow up data
of patients treated at our two institutions was obtained
from hospital medical records. Follow up duration was
defined as the time interval between the date of diagnosis
and date of last follow up. For patients treated at other
hospitals, follow up data was obtained from the guardians through interview conducted via telephone. Interview questions were pre-designed and a proforma was
filled for each case. Follow up data was obtained from 14
patients. As this was a descriptive cross-sectional study,
no statistical tests were applied. However, descriptive
statistics such as mean, standard deviation and median
for quantitative data and percentages for qualitative data
were calculated after the data was entered in SPSS version 19 software.
Results

Patients’ ages ranged from 8 months to 18 years, mean
and median age 4.1 and 2.5 years, respectively. 17 (74%)
were males and 6 (26%) were females (Male:female ratio:
2.8:1).
All patients presented with progressively enlarging
painless swelling. Most common locations were lower
extremities (thigh 6, leg 1, foot 2) abdominal cavity/retroperitoneum (n = 4) and scrotum/groin (n = 3) (Table 1).
Grossly, 22 tumors were circumscribed and multinodular (Fig. 1a). One case had infiltrative margins. Tumor
size ranged from 4.5 to 21 cm (mean, 10.8; median,
9.2 cm). Histologically, all showed lobules composed
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Table 1 Summary of clinicopathological findings (n = 23)
Serial #

Age

Gender Tumor size (cm) Tumor site

1

2–5 years

Female

13

Retroperitoneum

2

< 2 year

Male

12.5

Back

3

2–5 years

Male

4.5

Neck

4

2–5 years

Male

22

Scrotum

5

2–5 years

Male

7

Groin

6

< 2 year

Male

15

Axilla

7

6–12 years Male

N/A

Neck, parotid region

8

2–5 years

28

Retroperitoneum

Male

9

< 2 year

Male

5.5

Scrotum

10

< 2 year

Male

10.5

Abdomen

11

< 2 year

Male

7.5

Mesentery

12

6–12 years Male

8.5

Foot

13

6–12 years Female

10

Foot heel

14

6–12 years Male

11

Thigh

15

> 12 years

Female

21

Mediastinum

16

> 12 years

Male

10

Thigh

17

< 2 year

Male

9

Leg

18

< 2 year

Male

9

Upper back

19

< 2 year

Male

4.5

Thigh

20

< 2 year

Male

8

Thigh

21

2–5 years

Female

7

Arm

22

2–5 years

Female

5

Thigh

23

< 2 year

Female

9.5

Thigh

of adipocytes and lipoblasts separated by fibrous septa.
A fine vascular network was seen. No nuclear atypia or
mitoses was seen (Fig. 1b–d). Focal or diffuse myxoid
change, encapsulation and septation were seen in all
cases. Lobulation was seen in 19 (82.6%) and zonation in
2 cases (8.6%) (Fig. 2a, b).
Immunohistochemically,
primitive
mesenchymal
cells were reactive for Desmin; adipocytes and vascular
endothelial cells demonstrated positivity for CD34; adipocytes were positive for S100 protein (Fig. 2c–e).
Follow-up data was available in 14 patients. 13 patients
were alive and well with no evidence of recurrence.
Only patient with recurrence was a 14-year-old female
with a mediastinal lipoblastoma with infiltrative margins who had multiple local recurrences at 17, 24, 45 and
47 months after surgery (Additional file 1: Table S1). The
remaining 9 patients received treatment at other institutions and their medical records were unavailable.
Discussion

Lipoblastomas are the second commonest pediatric
adipocytic tumors after lipomas. Magnetic resonance
imaging is the modality of choice for evaluation of
tumor extension and planning of excision [11, 15–17,
19, 26–28]. Majority are 5 cm or less in size. However,

Abdul‑Ghafar et al. BMC Res Notes (2018) 11:42

Page 3 of 6

Fig. 1 a Gross appearance of lipoblastoma. Tumor is encapsulated and cuut surface is yellow, soft and myxoid. Fibrous septations impart multi‑
nodular imparts appearance. b Microscopic features of of lipoblastoma. Fibrous septations divide the tumor into lobules. c Variable sized multivacu‑
olated lipoblasts (arrows) admixed with adipocytes. d Thin walled branching (plexiform) vasculature

larger tumors have been reported. Majority of tumors in
our study were greater than 5 cm in size, mean size was
10.8 cm. This may be related to late presentation owing
to poor socio-economic conditions and health facilities.
Grossly, these are soft, lobulated and yellow, white or
tan in color. Fat, myxoid nodules or cystic spaces separated by fine, white, fibrous septa are seen on cut surface
[9, 14–17, 19, 21, 22, 24, 27, 29]. All tumors in our study
were encapsulated, soft and showed fibrous septations.
Our findings were similar to those reported in various
published studies. Histologically, characteristic lobular
architecture is seen with sheets of adipocytes separated
by fibrovascular septa. The adipocytes demonstrate different stages of maturation from primitive spindle cells
to vacuolated lipoblasts to mature adipocytes in varying
proportions. Myxoid areas with primitive mesenchymal cells and plexiform capillary network are seen. The
lobules show a zonal pattern of maturation with mature
adipocytes in the center and myxoid areas at the periphery. A greater proportion of mature adipocytes (lipomatous pattern) are an indication of maturation. Variable
numbers of residual lipoblasts are seen in less mature
myxoid areas [1, 2, 7, 9, 16, 24, 27]. Our findings were

similar to those reported in various studies. We did not
find any association between maturity and increasing age
of patient nor between maturation and tumor site. In one
study [16], lobules bordered by septa were seen in 44%,
prominent blood vessels in 76% and myxoid foci in 52%
cases. Mitoses are rare, abnormal mitoses are never seen
[9, 16, 17, 19–21, 23, 29]. On IHC, adipocytes are positive
for CD34 and S100 protein, while primitive cells are positive for Desmin [9]. Our findings were in concordance
with the reported findings.
The genetic hallmark are clonal rearrangements involving chromosomal region 8q11 > q13 (8q12). The oncogene PLAG1 (pleomorphic adenoma gene 1) is located
on band 8q12. PLAG1 is activated by a breakpoint in
the 8q11–13 region or polysomy of chromosome 8 [10,
11, 23, 25, 28–32]. Molecular analysis is important in the
accurate diagnosis and optimum management.
The differential diagnoses include pediatric lipoma,
hibernoma, pediatric myxoid liposarcoma (ML) and well
differentiated liposarcoma (WDL). Lipoblasts or primitive mesenchymal cells are not seen in lipomas while
hibernomas are composed of brown fat cells which
have a central nucleus and abundant finely granular
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Fig. 2 a Lipoblasts and plexiform vasculature is present against myxoid background. b Zonation; primitive mesenchymal cells at the edge of
fibrous septa merging gradually with adipocytes. c Adipocytes and blood vessels demonstrating positive expression for CD34 IHC stain. d Adipo‑
cytes demonstrating positive expression for S100 IHC stain. e Primitive mesenchymal cells demonstrating positive expression for Desmin IHC stain

cytoplasm. Lipomas are not common in extremities and
do not show chromosome 8 abnormalities. MLs are very
rare in children under 10 and are always deeply situated;
lipoblastomas may be superficial or deep. MLs show
a characteristic ‘pulmonary edema’ pattern, which is
attributable to pools of stromal mucin. This is not seen
in lipoblastomas. MLs may have hypercellular areas while
lipoblastomas are uniformly hypocellular. MLs show
nuclear atypia and do not show the lobulated growth
pattern of lipoblastomas. In MLs, maturation occurs
towards the periphery while in lipoblastomas, maturation occurs towards the center of the lobules, periphery
is composed of more primitive cells. MLs do not show
chromosomal 8 rearrangements. They are characterized
in 95% cases by recurrent translocation t (12;16) q (13;
p11) which results in fusion of FUS-DDIT3 genes. It is
important to differentiate between lipoblastoma and ML

as the latter are malignant and require aggressive treatment. Immunohistochemically, liposarcomas are MDM2
and CDK4 positive while lipoblastomas are negative. The
majority of ML and WDL are positive for p16 while large
majority of lipoblastomas are negative. A negative p16
staining may be helpful in excluding liposarcoma in cases
occurring in adolescence or those with late recurrences
[33]. Chromosome 8 abnormalities are not seen in WDL.
The treatment of choice is complete surgical resection
with preservation of vital organs. Prognosis is excellent
after complete excision even in large tumors. Recurrence
rates vary from 13 to 46% depending on extent of resection. Clinical outcome depends on completeness of resection with a high recurrence rate in incompletely resected
tumors. Close follow up for minimum of 5 years is recommended. Various studies have not reported any recurrences in completely excised tumors with follow ups of
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2 months–10 years and median follow up times ranging
from 38 to 42 months [11, 14, 15, 19, 22, 24, 25, 27, 30].
In our study, 74% patients were males. Male predominance was noted in multiple studies [1, 2, 5, 6, 8, 24,
27]. In our series, age range was 8 months–18 years, 11
(47.8%) patients were younger than 3 years of age, 16
(69.6%) were 5 years or younger and 19 (82.6%) were
10 years or younger. In Coffin et al.’s series [1], about 90%
patients were 10 years or younger. In another series [16],
84% patients were younger than 5 years. In various studies [1, 24, 27], ages ranged from 3 months to 16 years.
Most common locations include extremities and trunk
[10–15]. Ten cases (43.5%) in our study were located in
the extremities, thigh was the commonest location (26%).
In one study, 41% were located in the lower extremities
while 10% were located in the trunk [34]. In another
study, 44% were located in the extremities [16]. As many
as 64% cases in one review were located in the trunk [1].
22 cases were discrete with intact capsules. In contrast, only 44% tumors reviewed by Collins and Chatten
[16] were discrete while 56% had irregular margins. Head
and neck was a common location (16,18). In our series, 2
(8.6%) cases were located in the head and neck.
All patients presented with progressively enlarging
painless swelling, the commonest complaint [16, 24, 27]
seen in up to 92% cases.
Tumor size ranged from 4.5 to 21 cm, mean and
median size, 10.8 and 9.2 cm, larger compared to average
reported size (5 cm or less). 16 (69.6%) cases were larger
than 5 while 10 (43.5%) were larger than 10 cm. In one
study [16], 60% measured less than 5 cm. Various studies
reported tumor sizes between 5 and 15 cm [24, 27]. The
largest reported case measured 26 × 21 cm [35]. Grossly,
all cases showed lobulated appearance, were soft in consistency and had a yellowish and myxoid cut surface. One
case had infiltrative margins.
IHC (CD34, S100 protein and Desmin) was performed
in all cases, often retrospectively when the authors
reviewed the slides. We recommend routine IHC staining in all pediatric lipomatous tumors since these help
in accurate diagnosis especially in cases with equivocal
morphologic features. Follow up was available in 14 cases
(Additional file 1: Table S1). Follow up period ranged
from 1 to 109 months, median time of follow up was
12 months. Only 1 patient, a 14-year-old girl with a mediastinal lipoblastoma developed 4 separate recurrences at
17, 24, 45 and 47 months and underwent repeated resections. The remaining 13 were alive and free of disease
with no recurrences. A number of studies did not report
any recurrence during follow up periods of 1–2 years [17,
19], a case of inguinolabial lipoblastoma did not recur
after 6 years of follow up [22]. A low rate of recurrence
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was reported by Fallon et al. [32]. Two recent studies [24,
27] reported no recurrences in any of their patients with
median follow up of 42 months (range 18–84 months)
and 38 months (range 1.8 months–10 years) respectively.
Complete surgical resection and follow up for minimum of 5 years is essential. It is hoped that this series will
help in increasing awareness in our region about these
rare tumors among surgeons and pathologists. Pathology departments will be encouraged to develop protocols
regarding use of various IHC stains in accurate diagnosis
of pediatric adipocytic neoplasms. Correlation between
clinical and histological features helps in reaching an
accurate diagnosis. Confirmation by molecular studies is
recommended.

Limitations
The main limitation of our study was small sample size
(23 cases) but it needs to be emphasized that lipoblastomas are rare tumors, these 23 cases comprise all cases
diagnosed in our two institutions over a 10 year period
and represent the largest series on these rare tumors
from this region. Absence of follow up in some cases
was another limitation and was mainly because in many
remote regions of both countries, communication facilities are suboptimal.
Additional file
Additional file 1: Table S1. Follow up of patients (n = 14).
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